Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
M Omata, LA Lesmana, R Tateishi, PJ Chen… - Hepatology …, 2010 - Springer
Abstract Introduction The Asian Pacific Association for the Study of the Liver (APASL)
convened an international working party on the management of hepatocellular carcinoma …
convened an international working party on the management of hepatocellular carcinoma …
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives
YC Shen, C Hsu, AL Cheng - Journal of gastroenterology, 2010 - Springer
Sorafenib, a multikinase inhibitor targeting vascular endothelial growth factor (VEGF)-
mediated angiogenesis, is the first drug found to prolong survival of patients with advanced …
mediated angiogenesis, is the first drug found to prolong survival of patients with advanced …
Therapeutics based on microRNA: a new approach for liver cancer
G Zhang, Q Wang, R Xu - Current Genomics, 2010 - ingentaconnect.com
Hepatocellular carcinoma (HCC) is a serious public health hazard. Polygenes involvement,
accumulation of genetic and epigenetic changes and immune response of viral vector …
accumulation of genetic and epigenetic changes and immune response of viral vector …
Clinical development and future direction for the treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and about
600,000 patients suffer from HCC annually. The highest incidence is in Southeastern and …
600,000 patients suffer from HCC annually. The highest incidence is in Southeastern and …
Strategies for overcoming chemotherapy resistance in enterohepatic tumours
JJG Marin, B Castano, AG Blazquez… - Current molecular …, 2010 - ingentaconnect.com
When considered together, enterohepatic tumours, ie, those affecting the liver, the biliary
tree and gallbladder and the intestine, constitute the first cause of death due to cancer …
tree and gallbladder and the intestine, constitute the first cause of death due to cancer …
Liver cancer
JD Thomas, GA Poultsides, TM Pawlick… - … oncology: A practical …, 2010 - Springer
Liver Cancer | SpringerLink Skip to main content Advertisement SpringerLink Account Menu
Find a journal Publish with us Track your research Search Cart Book cover Gastrointestinal …
Find a journal Publish with us Track your research Search Cart Book cover Gastrointestinal …
Tratamiento del carcinoma hepatocelular avanzado
A Forner, CR De Lope, M Reig, J Bruix - Gastroenterología y hepatología, 2010 - Elsevier
En los últimos años hemos presenciado grandes progresos en el diagnóstico y tratamiento
del carcinoma hepatocelular (CHC). Esto ha permitido cambiar la visión nihilista que se …
del carcinoma hepatocelular (CHC). Esto ha permitido cambiar la visión nihilista que se …
[PDF][PDF] Aktuálny stav systémovej terapie nádorov pečene
MUDT Šálek - 2010 - solen.sk
Worldwide, hepatocellular carcinoma (HCC) is the fifth most common cancer and the third
most common cause of cancer-relateddeath. Unresectable or metastatic HCC carries a poor …
most common cause of cancer-relateddeath. Unresectable or metastatic HCC carries a poor …
[PDF][PDF] Targeted Therapies for the Systemic Treatment of Advanced Hepatocellular Carcinoma
F Chionh, A Azad, J Cebon - Asia Pacific Journal of Oncology & …, 2010 - researchgate.net
Advanced hepatocellular carcinoma is the third most common cause of cancer-related
mortality worldwide. Systemic therapy has historically had limited efficacy; however, targeted …
mortality worldwide. Systemic therapy has historically had limited efficacy; however, targeted …